Evidence map›Paper›PMID 26322085›Full record

ArticleArchives of medical science : AMS2015

Patients with heart failure and concomitant chronic obstructive pulmonary disease participating in the Heart Failure Pilot Survey (ESC-HF Pilot) - Polish population.

Ewa Straburzyńska-Migaj, Marta Kałużna-Oleksy, Aldo Pietro Maggioni, Stefan Grajek, Grzegorz Opolski, Piotr Ponikowski, Ewa Jankowska, Paweł Balsam, Lech Poloński, Jarosław Drożdż

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of medical science : AMS, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Ewa Straburzyńska-Migaj1 Department of Cardiology, University Hospital "Przemienienia Pańskiego", Poznan University of Medical Sciences, Poznan, Poland.
Marta Kałużna-Oleksy1 Department of Cardiology, University Hospital "Przemienienia Pańskiego", Poznan University of Medical Sciences, Poznan, Poland.
Aldo Pietro MaggioniANMCO Research Center, Florence, Italy.
Stefan Grajek1 Department of Cardiology, University Hospital "Przemienienia Pańskiego", Poznan University of Medical Sciences, Poznan, Poland.
Grzegorz Opolski1 Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
Piotr PonikowskiDepartment of Cardiology, 4 Military Hospital, Medical University of Wroclaw, Wroclaw, Poland.
Ewa JankowskaDepartment of Cardiology, 4 Military Hospital, Medical University of Wroclaw, Wroclaw, Poland.
Paweł Balsam1 Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
Lech Poloński3 Chair and Department of Cardiology, Silesian Centre for Heart Diseases, Medical University of Silesia in Katowice, Medical Faculty in Zabrze, Poland.
Jarosław DrożdżDepartment of Cardiology, Medical University of Lodz, Lodz, Poland.
Medical University of Warsaw · PLPoznan University of Medical Sciences · PLAssociazione Nazionale Medici Cardiologi Ospedalieri · ITMedical University of Lodz · PLUniversity of Wrocław · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThere is an increasing interest in comorbidities in heart failure patients. Data about chronic obstructive pulmonary disease (COPD) in the Polish population of heart failure (HF) patients are scarce. The aim of this study was to investigate the clinical characteristics, treatment differences and outcome according to COPD occurrence in the Polish population of patients participating in the ESC-HF Pilot Survey Registry. MATERIAL AND

methodsWe analyzed the data of 891 patients with HF recruited in 2009-2011 in Poland: 648 (72.7%) hospitalized patients and 243 (27.3%) patients included as outpatients.

resultsThe COPD was documented in 110 (12.3%) patients with HF in the analyzed population. Patients with - compared to those without COPD were older, more often smokers, had higher NYHA class, and higher prevalence of hypertension. Ejection fraction (EF) was higher in hospitalized patients with COPD compared to patients without COPD (40.5 ±14.6% vs. 37.2 ±13.7%, p < 0.04), without a significant difference in the outpatient group. There was a significant difference in β-blocker use between patients with and without COPD (81.8% vs. 94.7%, p < 0.0001). Most patients received them below target doses. At the end of the 12-month follow-up, there was no significant difference in mortality between COPD and no-COPD patients (10.9% vs. 11.1%, p = 0.66).

conclusionsThe findings from the Polish part of the ESC-HF registry indicate that COPD in patients with HF is associated with older age, smoker status, hypertension and higher NYHA class. The use of β-blockers was significantly lower in patients with than without COPD. There were no significant differences in mortality between groups.

Indexed as

chronic heart failurechronic obstructive pulmonary diseaseβ-blocker

Identifiers

PMID26322085
PMCPMC4548022
OpenAlexW1968591364

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.